A detailed history of Voya Investment Management LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 13,216 shares of LUNG stock, worth $83,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,216
Previous 13,060 1.19%
Holding current value
$83,789
Previous $82,000 32.93%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.59 - $8.58 $872 - $1,338
156 Added 1.19%
13,216 $109,000
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $5,198 - $8,847
901 Added 7.41%
13,060 $82,000
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $25,929 - $43,613
-2,977 Reduced 19.67%
12,159 $112,000
Q3 2023

Nov 14, 2023

BUY
$9.88 - $14.0 $4,386 - $6,216
444 Added 3.02%
15,136 $156,000
Q2 2023

Aug 14, 2023

BUY
$10.78 - $13.65 $15,577 - $19,724
1,445 Added 10.91%
14,692 $192,000
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $12,694 - $19,839
827 Added 6.66%
13,247 $221,000
Q2 2022

Aug 15, 2022

BUY
$14.0 - $27.95 $24,612 - $49,136
1,758 Added 16.49%
12,420 $183,000
Q1 2022

May 16, 2022

BUY
$21.13 - $35.65 $4,690 - $7,914
222 Added 2.13%
10,662 $265,000
Q4 2021

Feb 14, 2022

BUY
$29.72 - $45.1 $3,417 - $5,186
115 Added 1.11%
10,440 $335,000
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $15,399 - $19,037
428 Added 4.32%
10,325 $371,000
Q2 2021

Aug 16, 2021

BUY
$37.61 - $48.0 $177,481 - $226,512
4,719 Added 91.14%
9,897 $437,000
Q1 2021

May 17, 2021

BUY
$44.0 - $67.54 $58,476 - $89,760
1,329 Added 34.53%
5,178 $237,000
Q4 2020

Feb 16, 2021

BUY
$39.31 - $69.02 $151,304 - $265,657
3,849 New
3,849 $266,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.